Počet záznamů: 1
Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines
SYS 0191582 LBL 00000nam^^22^^^^^^^^450 005 20230418185542.4 101 0-
$a eng $d eng 102 $a GR 200 1-
$a Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines 215 $a 5 s. 463 -1
$1 001 cav_un_epca*0256808 $1 011 $a 1019-6439 $e 1791-2423 $1 200 1 $a International Journal of Oncology $v Roč. 22, č. 3 (2003), s. 691-695 $1 210 $c Spandidos Publications 610 1-
$a chemotherapy-induced residual tumour disease 610 1-
$a immunotherapy 610 1-
$a HPV16-associated tumours 700 -1
$3 cav_un_auth*0105388 $a Indrová $b Marie $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105331 $a Bubeník $b Jan $p UMG-J $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105451 $a Mikyšková $b Romana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105448 $a Mendoza $b Luis $p UMG-J $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105504 $a Šímová $b Jana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105320 $a Bieblová $b Jana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105390 $a Jandlová $b Táňa $p UMG-J $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0020323 $a Jinoch $b P. $y CZ $4 070 701 -1
$3 cav_un_auth*0014925 $a Šmahel $b M. $y CZ $4 070 701 -1
$3 cav_un_auth*0020321 $a Vonka $b V. $y CZ $4 070 701 -1
$3 cav_un_auth*0015365 $a Pajtasz-Piasecka $b E. $y PL $4 070
Počet záznamů: 1